Adapted Physical Activity Effect on Abilities and Quality of Life of Huntington Patients and Relatives During Rehab Stay
Condition:   Huntington Disease Interventions:   Behavioral: Adapted Physical Activity program;   Other: Control Sponsors:   Assistance Publique - Hôpitaux de Paris;   Euromov Digital Health in Motion Montpellier France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease
Condition:   Huntington Disease Intervention:   Genetic: Intraparenchymal rAAV1 - miHTT Sponsor:   Voyager Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2021 Category: Research Source Type: clinical trials

Preparing for Prevention of Huntington's Disease (PREVENT-HD)
Condition:   Huntington Disease Interventions:   Other: Clinical Assessments;   Diagnostic Test: MRI Scan;   Diagnostic Test: Lumber Puncture (LP) Sponsors:   University of Wisconsin, Madison;   National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2021 Category: Research Source Type: clinical trials

Genentech Provides Update on Tominersen Program in Manifest Huntington ’s Disease
South San Francisco, CA -- March 22, 2021 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen in manifest Huntington’s... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 22, 2021 Category: Pharmaceuticals Source Type: clinical trials

Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
Condition:   Huntington Disease Intervention:   Drug: Deutetrabenazine Sponsors:   Vanderbilt University Medical Center;   Teva Branded Pharmaceutical Products R&D,  Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2021 Category: Research Source Type: clinical trials

Synaptic Density and Progression of Huntington's Disease.
Condition:   Huntington Disease Interventions:   Diagnostic Test: 11C-UCB-J PET-CT;   Diagnostic Test: 18F-FDG PET-MR Sponsor:   Universitaire Ziekenhuizen Leuven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2021 Category: Research Source Type: clinical trials